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real-time three-dimensional echocardiogram:
Comparative study with 2D echocardiogram
and angiographyAlaa Roushdy a,⇑, Azza El Fiky b, Dina Ezz el Din ca–c Cardiology Department, Ain Shams University Hospital, Cairo
a–c EgyptPurpose: To determine the feasibility and accuracy of real time 3D echocardiography (RT3DE) in determining the
dimensions and anatomical type of the patent ductus arteriosus (PDA).
Methods: The study included 42 pediatric patients with a mean age of 3.6 years (ranging from 2 months to
14 years) who were referred for elective percutaneous PDA closure. All patients underwent full 2D echocardio-
gram as well as RT3DE with off line analysis using Q lab software within 6 h from their angiograms. The
PDA was studied as regard the anatomical type, length of the duct as well as the ampulla and the pulmonary
end of the PDA. Data obtained by RT3DE was compared against 2D echocardiogram and the gold standard angi-
ography.
Results: Offline analysis of the PDA was feasible in 97.6% of the cases while determination of the anatomical
type using gated color flow 3D acquisitions was achieved in 78.5% of the cases. The pulmonary end of the duct
was rather elliptical using 3D echocardiogram. There was significant difference between the pulmonary end mea-
sured by 3D echocardiogram and angiography (P < 0.001). There was no significant difference between either the
length or the ampulla of the PDA measured by 3D echocardiogram and that measured by angiography (P
value = 0.325 and 0.611, respectively). There was a good agreement between both 2D or 3D echocardiogram and
angiography in determining the anatomical type of the PDA (K = 0.744 and 0.773, respectively). However 3D echo-
cardiogram could more accurately determine type A and type E ductus compared to 2D echocardiogram.
Conclusion: 3D echocardiogram was more accurate than 2D echocardiogram in determining the length and the
ampulla of the PDA. The morphologic assessment of the PDA using gated 3D color flow was achieved in 78.5% of
the patients. Nevertheless the use of 3D echocardiogram in assessment of small vascular structures like PDA in
children with rapid heart rates is still of limited clinical value.
 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
Keywords: PDA, Congenital heart disease, RT3DE, Three-dimensional echocardiographyAbbreviations: 2D, two-dimensional; 3D, three-dimensional; CHD, congenital heart disease; MPR, multiplane
reformatted mode; PDA, patent ductus arteriosus; RAO, right anterior oblique; RVOT, right ventricular outflow tract1016–7315  2012 King Saud University.
Production and hosting by Elsevier B.V. All rights reserved.
Peer review under responsibility of King Saud University.
URL: www.ksu.edu.sa
http://dx.doi.org/10.1016/j.jsha.2012.02.001
Production and hosting by Elsevier
O
R
IG
IN
A
L A
RTIC
LE
178 ROUSHDY ET AL
VISUALIZATION OF PDA USING RT3DE
J Saudi Heart Assoc
2012;24:177–186Introduction
Patent ductus arteriosus (PDA) accounts for5–10% of all congenital heart diseases
(CHD). It occurs more commonly in premature
infants, where 8 out of 1000 premature infants
have PDA compared to 2 out of 1000 term infants.
It is more common in females with a female to
male ratio of 3:1 [12].
The physiological impact and clinical
significance of the PDA depend largely on its size
and the underlying cardiovascular status of the
patient. The PDA may be ‘‘silent’’ (not evident
clinically but diagnosed incidentally by echocardi-
ography performed for a different reason), small,
moderate, or large [14].
In 1989 Krichenco et al. classified PDA according
to its angiographic appearance into five types:
type A ‘‘conical’’ ductus, with well-defined aortic
ampulla and constriction near the pulmonary
artery end. Type B, very large ‘‘window’’ ductus,
with very short length. Type C, ‘‘tubular’’ ductus,
which is without constrictions. Type D, ‘‘complex’’
ductus, which has multiple constrictions. Type E,
‘‘elongated’’ ductus, with the constriction remote
from the anterior edge of the trachea [7].
Available treatment modalities include surgical
ligation in large ducts not suitable for interven-
tional treatment and transcatheter closure for
small to moderate sized ducts whether by coil
embolization or occluder devices. Accurate assess-
ment of the size, shape and anatomical type of the
PDA represents a crucial step to choosing the most
suitable technique that will guarantee complete
closure of the PDA without complications [6,13].
Two-dimensional (2D) echocardiography is an
important diagnostic tool and is a mainstay forFigure 1. Full volume acquisition as seen from a modified parasternal
short-axis view (left infraclavicular approach) showing the entrance
of the PDA into the left pulmonary artery (black arrow).the diagnosis and evaluation prior to manage-
ment. Cardiac catheterization is also used to
revaluate the PDA prior to its percutaneous
closure [14]. With the recent introduction of 3D
echocardiography and its unique ability to allow
real time volumetric imaging and thus improv-
ing the accuracy of evaluating the cardiac cham-
bers, the idea of using this unique capability in
interrogating extra cardiac vascular structures
like the PDA to optimize the management seems
appealing. In this study we sought to determine
the feasibility and accuracy of real time 3D
echocardiography (RT3DE) in determining the
dimensions and anatomical type of the PDA
and compare the data obtained with that from
2D echocardiography and the gold standard
angiography.Methods
This study was approved by our institutional
review board and informed consent was obtained
from the parents of all the children enrolled in the
study.
This study was a prospective study which
included 42 consecutive patients with PDA who
were referred for elective percutaneous PDA
closure. All patients were subjected to full echo-
cardiographic study including RT3DE using an
iE33 Philips machine with matrix array transducer
followed by cardiac catheterization. The results
obtained from 2D echocardiogram, 3D echocar-
diogram and angiography were blinded to each
other.
Echocardiography
All patients underwent echocardiographic
studies using a Philips iE33 machine (Philips
Medical Systems, Andover, MA). Standard 2D
echocardiogram was done for all patients enrolled
in the study using phased array transducers of
different frequencies tailored according to each
patient’s age, body built and weight. Philips S8-3
Sector Array Transducer with a frequency range
from 8 to 3 MHz was generally used for children
below 3 years of age and Philips S5-1 Sector Array
Transducer with a frequency range from 5 to
1 MHz was used for older children with few
exceptions.
The study included 2D, M-mode and color flow
Doppler from all standard echocardiographic
windows (i.e. subcostal, apical, parasternal and
suprasternal) applying the sequential analysis to
establish the situs, AV and VA connections, great
vessel relation and abnormalities, ventricular
Figure 2. Multiplane reformatted window as seen in the QLAB offline analysis software. Three different projections are seen, the coronal (green
square), the sagittal (red square) and the transverse (blue square), the pulmonary end of the duct is marked by the point of intersection of the
green and red lines in the blue square.
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VISUALIZATION OF PDA USING RT3DEdimensions and functions, state of cardiac valves,
venous connections, and any intra cardiac shunts
[17].
Three views were used in the 2D echocardio-
gram to visualize the duct and its course; the high
left parasternal long-axis scan of the pulmonary
artery or the ‘‘ductal view’’, the suprasternal and
parasternal short-axis views (at the level of the
pulmonary artery bifurcation). 2D and color flow
mapping were used to evaluate the site and shape
of the PDA and asses the diameter of the ampulla
and the pulmonary end as well as the length of the
duct. The pressure gradient across the duct was
recorded using continuous wave Doppler [17].3D echocardiography
After completing the 2D echocardiogram, all the
subjects underwent full 3D study using a pediatric
matrix probe X7-2 in infants and children up to3 years of age with a frequency range from 7 to
2 MHz and an adult matrix probe X3-1 in older
children with frequency range from 3 to 1 MHz.
Image acquisition was adjusted in accordance
with the ‘‘Practical Guide for Three Dimensional
Transthoracic Echocardiography’’ [20]. Frame
rates were generally in the range of 42 for full vol-
ume mode and 24 for 3D color mode.
Two modes of acquisition were used in this
study; narrow angle live 3D imaging was first per-
formed in all conventional 2D planes followed by
ECG gated full volume acquisition. Two fixed full
volumes were acquired for all patients; the supra-
sternal short axis and the left infraclavicular
(Fig. 1).
Offline analysis was applied to the volume ren-
dered data using the ‘‘QLAB’’ software system
version 7.0 with 3DQ application. Multiplane
reformatted mode (MPR) was used to delineate
the PDA in three planes at the same time. Each
Table 1. 2D echocardiographic data of the study group.
Range Mean ± SD
LV EDD (mm) 16.0–57.0 32.1 ± 8.6
LV ESD (mm) 8.0–39.0 20.1 ± 6.4
IVS (mm) 3.0–8.0 4.5 ± 1.2
FS (%) 25.0–48.0 35.8 ± 5.9
EF (%) 55.0–80.0 67.95 ± 7.55
Gradient (mmHg) 17.0–130.0 73.2 ± 22.7
PDA Pulmonary end (mm) 1.3–4 2.4 ± 0.7
PDA ampulla (mm) 4–11 7.12 ± 1.5
Length of the PDA (mm) 4–11 7.1 ± 1.75
LV EDD: left ventricle end diastolic dimension, LV ESD: left ventricle
end systolic dimension, IVS: inter ventricular septum, FS: fractional
shortening, EF: ejection fraction, PDA: patent ductus arteriosus.
Figure 3. Gated color flow 3D acquisition as seen from the left
infraclavicular projection (A) and after cropping and black and white
suppression (B).
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other two planes. This line allows moving or rotat-
ing the plane within the volume data. The point of
intersection of the three lines can be moved in the
three planes simultaneously to display the multi-
planar projection of the PDA (Fig. 2).
The MPR planes were used to display the pul-
monary end of the duct and measure it in two
dimensions by adjusting the pulmonary end in
the coronal plane and then measuring it in the
transverse plane. The length of the duct as well
as the diameter of the ampulla was also measured
from the coronal plane.Gated color volumes
ECG gated color acquisition was taken to assess
the flow across the PDA and into the pulmonary
artery. The gated color flow 3D acquisition stitches
seven consecutive cycles. The color gain was chan-
ged to allow for the best display and the most flex-
ible post-processing manipulation. PDA flow was
acquired from the suprasternal long-axis view to-
gether with the aortic arch flow or from the infra-
clavicular view (Fig. 3A).
Gated color flow was useful in determining the
shape of the duct by cropping the color flow after
adjusting the color gain to get the best display.
The crop box was used to crop the duct till the
shape of the duct appears. Black and white sup-
pression was also used after cropping to eliminate
the surrounding tissue and thus allow better
delineation of the duct through its course
(Fig. 3B). Gated color flow was considered feasible
if we could visualize the three main parts of thePDA; namely the ampulla, the body of the PDA
and its pulmonary end as a colored filled cast by
3D color flow. The absence of any of these three
parts deemed the patient not suitable for assess-
ment (Fig. 3).
Cardiac catheterization
In all patients arterial and venous access was
established using the Seldinger’s technique fol-
lowed by administration of 50 IU/kg heparin.
Angiographic visualization of the duct
An angiographic catheter was positioned in the
descending aorta just distal to the expected loca-
tion of the PDA. The initial angiogram was taken
in the lateral projection if the lateral view showed
the PDA shape adequately then the measure-
ments were taken from the lateral view and
assessment of the anatomical type was deter-
mined based on the Krichenko classification [7].
However in some patients the right anterior
oblique (RAO) cranial view 35–40 was needed
for further evaluation of the anatomical type of
the PDA.
After angiographic evaluation the pulmonary
end, the aortic end and the length of the duct were
measured in millimeters using the software incor-
porated within the cath. Lab machine. The duct
was measured in lateral angiogram where the pul-
monary end was measured as the narrowest part
of the duct facing the pulmonary artery, the aortic
end was measured as the widest part towards the
aorta and the length was measured as a line from
the midpoint of the pulmonary end till the
midpoint of the ampulla.
Statistical analysis
Data were coded and analyzed using the SPSS
program version 18.0 (Statistical Package for So-
cial Sciences). Qualitative data were presented
Figure 4. Distribution of the anatomical types of the PDA by 2D, 3D echocardiography and angiography.
Table 2. Comparison between the 2D, 3D echocardiography
and angiography regarding the pulmonary end of the duct.
PDA pulmonary end (in mm)
Range Mean ± SD Paired test
t P-value
Angiography 1.00–4.10 2.3 ± 0.8
2D 1.30–4.00 2.35 ± 0.7 1.07 0.289
3D (narrowest) 1.10–3.40 1.8 ± 0.5 3.83 <0.001
3D (widest) 1.6–4.5 2.6 ± 0.7 3.62 <0.001
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VISUALIZATION OF PDA USING RT3DEusing the frequency and its related percentage,
while quantitative data were presented using the
mean and standard deviation. Changes in contin-
uous variables were evaluated using the paired t-
test. A P-value of <0.05 was chosen as the level of
significance. Inter-rater agreement was used to
evaluate the agreement between the anatomical
types of the PDA determined by either 2D or 3D
echocardiography and the gold standard angio-
gram. Agreement is quantified using Kappa (K).
K is 1 when there is perfect agreement between
the anatomical types determined by echocardio-
gram and the gold standard angiography; K is 0
when there is no agreement better than chance
between the two methods.Results
The study included 42 pediatric patients with
PDA, 11 males (26%) and 31 females (73%), with
a mean age of 3.7 ± 3.6 years (range 2 months to
14 years). Of these patients, 41 (97.6%) had iso-
lated PDA and 1 patient had PDA and VSD
(2.3%). The heart rate of the patients had a mean
of 113 ± 23.6 beats per minute, the weight of the
patients ranged from 6 to 55 kg with a mean of
15 ± 10.8 kg, and the body surface area was
0.7 ± 0.4 m2.2D echocardiography data
Only two patients (4.7%) had dilated LV dimen-
sions for age, but all patients had normal LV
global systolic function with normal fractional
shortening and ejection fraction as measured by
applying the M-mode at the level of the LV-
papillary muscles in the standard parasternal
short-axis view using the Teichholtz formula [8].
Table 1 illustrates the data measured by 2D
echocardiogram.
The shape of the duct was then evaluated to
determine its anatomical type by 2D echocardiog-
raphy; 24 cases were type A (57%), 1 case was type
B (2.3%), 3 cases were type C (7%), 1 case was type
D (2.3%) and 13 cases were type E (30%) (Fig. 4).
3D echocardiography data
Among the 42 patients initially enrolled in the
study, 41(97.6%) were successfully assessed using
the ‘‘QLAB’’ software while one patient was
excluded due to poor image quality. In the 41
patients who were suitable for offline analysis
the following measurements were obtained:
The pulmonary end had a mean of 1.8 ± 0.5 mm
with a range of 1.1–3.4 mm. The aortic end ranged
from 3.4 to 11 mm with a mean of 7.7 ± 1.4 mm and
the length of the duct had a mean 7.6 ± 1.8 with a
range of 2.8–10 mm.
We were able to assess the anatomical type of
the duct by gated color flow and black and white
suppression in 33 cases (78.5%) while the anatom-
ical type of the remaining 9 (21.5%) cases could not
be assessed utilizing this technique due to the
presence of gaps in the color cast obtained by
gated 3D color flow mapping.
Out of the 33 cases that were possibly analyzed
using gated color flow 3D echocardiography with
black and white suppression; 17 were type A
Figure 5. Comparison between the anatomical types of the PDA as
determined by 2D echocardiogram versus the gold standard
angiography.
O
R
IG
IN
A
L A
RTIC
LE
182 ROUSHDY ET AL
VISUALIZATION OF PDA USING RT3DE
J Saudi Heart Assoc
2012;24:177–186(51.5%), 1 case was type B (3%), 3 cases were type
C (9%) and 12 cases were type E (36.3%) and none
of the ducts was type D (Fig. 4).
Angiographic data
The pulmonary end of the duct, the ampulla and
the entire length of the duct for each patient were
measured in the lateral aortogram. The pulmon-
ary end of the duct ranged from 1 to 4.1 mm (mean
2.3 ± 0.8 mm), the ampulla was in the range of
2–12 mm (mean 7.5 ± 2.1 mm) and the length ran-
ged from 2.6 to 12.9 mm (mean 7.8 ± 2.4 mm).
The lateral view was first used and adequately
visualized the duct in 18 cases (42.8%); however,
in the remaining 24 cases (57.1%) the RAO cranial
view was necessary to confirm the anatomical type
of the duct. The angiographically determined ana-
tomical types were: type A (n = 20, 47.6%), type B
(n = 1, 2.3%), type C (n = 2, 4.7%), type D (n = 2,
4.7%) and type E (n = 17, 40.4%) (Fig. 4).
Comparison between the pulmonary end
measured by 2D, 3D echocardiography and
angiography
Paired t-test was used to compare the pulmon-
ary end measured by the three modalities. There
was no significant difference between the pul-Table 3. Distribution of the anatomical types of the PDA by
2D, 3D echocardiography and angiography.
Type 2D 3D Angio
N % N % N %
A 24 57.14 17 51.52 20 47.62
B 1 2.38 1 3.03 1 2.38
C 3 7.14 3 9.09 2 4.76
D 1 2.38 0 0.00 2 4.76
E 13 30.95 12 36.36 17 40.48
Total 42 100.00 33 100.00 42 100.00monary end measured by 2D echocardiography
and that measured by angiography (P = 0.2). There
was a significant difference between the dimen-
sions measured by 3D echocardiography and the
pulmonary end measured by angiography
(P < 0.001) (Table 2).
Comparison between the ampulla measured by
2D, 3D echocardiography and angiography
The ampulla measured by 2D echocardiography
had a mean of 7.12 ± 1.5 mm, while that measured
by 3D echocardiography had a mean of 7.7 ±
1.4 mm. Both measurements compared favorably
with the gold standard measurement by angiogra-
phy which had a mean of 7.55 ± 2.1 mm. There was
no significant difference between the 3D measure-
ment and that by angiography (P = 0.6); however,
there was a tendency toward under-estimation of
the aortic end by 2D echocardiography compared
to that measured by angiography (P = 0.047).
Comparison between 2D, 3D echocardiography
and angiography regarding the length of the duct
The length of the duct measured by 2D echocar-
diography had a mean of 7.1 ± 1.7 mm, while that
measured by 3D echocardiography had a mean
of 7.6 ± 1.8 mm. The 3D echocardiography mea-
surement of the PDA length compared favorably
with its measurement by angiography which had
a mean of 7.8 ± 2.3 mm. (P = 0.3). However there
was a significant under-estimation of the PDA
length by 2D echocardiography compared to its
measurement by angiography (P = 0.004).
Comparison between 2D, 3D echocardiography
and angiography regarding the PDA anatomical
type
The anatomical types of the PDA determined by
either 2D or 3D echocardiography were comparedFigure 6. Comparison between the anatomical types of the PDA as
determined by 3D echocardiogram versus the gold standard
angiography.
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VISUALIZATION OF PDA USING RT3DEagainst the gold standard angiography. Table 3
shows the different PDA anatomical types as deter-
mined by each modality. There was a tendency to
over-diagnose type A ducts using 2D echocardiog-
raphy compared to angiography (57.14% versus
47.62%). This over-diagnosis improved after using
3D echocardiography (51.52% versus 47.62%).
There was also a tendency to under-diagnose type
E duct using 2D echocardiography compared to
angiography (30.95% versus 40.48%). This under-
diagnosis also improved after using 3D echocardi-
ography (36.36% versus 40.48%).
Nevertheless, the inter-rater agreement (K)
between either 2D or 3D echocardiographic deter-
mination of the anatomical type of the PDA and
that of catheterization was comparable. Both
methods showed good agreement with the gold
standard angiograms. The inter-rater agreement
of 2D echocardiography was 0.744 (standard error
of 0.097 and 95% CI 0.553–0.935) versus 0.773 (stan-
dard error of 0.096 and 95% CI 0.586–0.961) for 3D
echocardiogram (Fig. 5 and 6).Discussion
Echocardiography has evolved into the most
predominant diagnostic imaging technique in car-
diology. Over the last five decades the diagnostic
capability of echocardiography has increased
dramatically from M-mode to 2D imaging. Recent
advances in ultrasound instrumentation and com-
puter technology has led to the evolution of 3D
echocardiography, introducing a new era in car-
diovascular imaging [18].
3D echocardiography is still in its evolution and
at the phase of early adaptation with respect to its
clinical application. It should complement current
echocardiographic techniques by providing better
understanding of the topographical aspects of
pathology and refined definition of the spatial
relationships of (intra)cardiac structures [18].
The use of RT3DE in CHD was discussed in
several studies with a documented role in assess-
ment of septal defects [3,11]. The present study
was designed to assess the value of RT3DE in
the evaluation of PDA regarding the anatomical
type of the duct and its measurements. The first
published report of 3D echocardiographic evalua-
tion of a PDA was that of Sinha et al. in 2004. The
authors studied a 24-year-old female where 2D
echocardiography was used to reveal the PDA,
but the length, shape, size of the duct and its
attachment to the pulmonary and descending
thoracic aorta could not be evaluated and there-
fore 3D echocardiography was performed usinga Philips Sonos Ultrasound System with TomTec
software offline analysis. In this report the images
were cropped using the crop box and the color
flow was used to delineate the anatomical type
of the duct similar to the current study.
Vazquez-Antona et al. back in 2006 published an
abstract titled ‘‘Three-dimensional echocardiogra-
phy in evaluation of PDA before and after percu-
taneous closure’’. However the authors of this
study stated that the purpose of their study was
to assess the ability of 3D echocardiography to
accurately view the anatomic details of patients
with PDA. They studied 21 patients, and of these
11 had 3D echocardiography actually done after
percutaneous closure to assess the spatial relation
of the device to the surrounding anatomic struc-
tures. In 10 patients the size and morphology of
the duct was compared between 2D and 3D echo-
cardiography prior to closure. However the
authors did not include any comparative details
between the two methods and reviewing the liter-
ature showed that this study never materialized
into a full text article to be discussed in details
[19]. In comparison, the current study included
42 patients for which detailed measurements was
taken by 2D and 3D echocardiography and the
measurements were compared to the gold stan-
dard angiograms.
In 2008, Bharucha and colleagues examined 300
cases with congenital cardiac malformations and
found that 3D echocardiography; mainly the
MPR mode, was of great use and changed the
management plane in 32 cases. However there
were no PDA cases in that study [2].
In the current study the MPR mode was used in
all the feasible cases (41 cases were feasibly as-
sessed by QLAB out of 42 cases) where after the
duct was adequately visualized from the supra-
sternal short axis or the left infraclavicular view
the MPR mode was used to measure the pulmon-
ary end of the duct in two dimensions (minor and
major). The shape of the pulmonary end was
found to be elliptical rather than rounded and
the two dimensions measured differed from those
measured by 2D echocardiography or angiogra-
phy. We postulate that 3D echocardiography
might be measuring the pulmonary end from a
different angle than that measured by angiogra-
phy and 2D echocardiography.
Anwar and colleagues studied the right ventric-
ular outflow tract (RVOT) and the pulmonary
valve in 50 adult cases. They compared the mea-
surement of RVOT diameter and the PV annulus
using both 2D and 3D echocardiography. In accor-
dance to our results, the authors concluded that
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were underestimated and smaller than 3D diame-
ters which mean they were tangential rather than
true cut sections [1].
In the current study the aortic end of the duct
measured by 3D guided method was better than
2D echocardiography when both were compared
with the gold standard angiography. The length
of the duct was also measured in a 3D guided
MPR mode and had better agreement with angi-
ography than the classic 2D echocardiogram mea-
surements. We postulate that the third dimension
and the ability of 3D echocardiography to deter-
mine the depth of anatomic structures improved
assessment of the length of the PDA compared
to 2D echocardiogram.Figure 7. Comparison between 3D color flow imaging to determine the ana
type of the same patient(s) as determined by angiogram (right side), (A and
echocardiogram and angiography, respectively. (C and D) Type E ductus o
black and white suppression and angiography, respectively.The anatomical type of the duct was determined
using 3D gated color flow across the PDA followed
by black and white suppression. The shape of the
duct appeared after cropping of the image as a
colored cast that resembles more or less a 3D
angiographic display of the duct. When feasible
3D echocardiography color flow mapping pro-
vided excellent angiographic display of full extent
of the PDA flow from the aortic to the pulmonary
ends. Moreover, with rotation of the volume, dif-
ferent views of the duct can be displayed simulat-
ing the lateral and RAO angiographic views that
allowed better understanding of the ductal mor-
phology. The anatomical type of the duct was
determined according to Krichenko classification
[7] (Fig. 7).tomical type of the PDA (left side) and the corresponding anatomical
B) type A ductus of the same patient as determined by 3D color flow
f another patient as determined by 3D color flow echocardiogram with
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and white suppression was adopted from the
technique used by Mallek et al. who studied the
‘‘Angiographic visualization of MBT shunts by
3D echocardiogram’’ and stated that surgical
shunts were by far better visualized using the
gated 3D color volumes from origin to insertion
into the pulmonary tree with demonstration of
the whole extent of the shunt in one image com-
pared to 2D echocardiography [9].
Seliem et al. [15] studied RT3DE imaging of
CHD using matrix-array technology in 70 patients.
The morphology of the blood flow in the blood
vessels (e.g., branch pulmonary arteries, ductus
arteriosus, surgical shunts, and aorta) was studied
in only five of these patients and yielded color
flow echocardiographic angiograms that could be
rotated 360 and inspected from different angles.
In the study by Del Pasqua and colleagues both
full volumes and gated 3D color volumes provided
the diagnosis in 3 cases with extra cardiac anoma-
lies (aberrant left subclavian artery in right sided
arch with a ductus arising from Kommerel’s diver-
ticulum, tortuous right PDA in a left sided arch
and an aberrant right subclavian artery in a left
aortic arch) [5].
There was a good agreement between either 2D
or 3D echocardiography and angiography in the
determination of the anatomical type of the
PDA. However when the study group was exam-
ined on individual bases 3D echocardiography
did improve the diagnosis in both type A and E
ductus.
This can be explained by the nature of type A
duct which is short and conical, while type E is
elongated and also conical and thus might be mis-
taken as type A by 2D echocardiography which
lacks the depth and the third dimension.
Type C ductus was over-diagnosed by both 2D
and 3D echocardiography. This might be due to
the tubular nature of type C which lacks a con-
striction which makes angiography more accurate
than echocardiography as the color flow might
mask a constriction due to inadequate color flow
gains. There were two type D ducts according to
angiography where 2D echocardiography de-
tected one of them and 3D echocardiography
could not detect any of them this can be explained
by the complex nature of type D (with multiple
constrictions) which will make echocardiographic
diagnosis more challenging.Study limitations
RT3DE is a relatively new technology, the full
potential of which has not been entirely definedespecially in the pediatric population, where im-
proved understanding of complex structural
CHD by noninvasive imaging is most rewarding.
Despite the advances in 3D echocardiographic
techniques, there are challenges which remain.
The resolution of the current matrix probes does
not quite match those of conventional ultrasound
probes, although the development of higher fre-
quency probes for pediatric use has been a major
advance.
Acquisition of the volumetric dataset still has to
be performed over several cardiac cycles so that
the problem of movement or respiratory motion
artifact remains. The basic physics of ultrasound
is not altered by the acquisition of a 3D dataset,
so that the technique remains dependent on cross
sectional image quality; i.e. the quality of any 3D
echocardiographic study is actually dependant
on the quality of the original 2D images from
which these 3D data sets are generated.
The frame rates achievable on 3D echocardiog-
raphy have improved recently but remain lower
than those obtained using conventional cross-sec-
tional probes in most of the cases. This remains a
problem for fast moving structures especially in
children with rapid heart rates.
Several studies have been performed to analyze
the usefulness of RT3DE in CHD. Very limited
data is available on RT3DE for imaging the PDA
[16,10,4]. Further studies are certainly welcome
and needed to define the RT3DE use with the
highest benefit/cost yield. Ideally, RT3DE should
prove to either:
a. Add reliable new information.
b. Be able to replace or meaningfully comple-
ment other imaging modalities at no addi-
tional cost (financial, manpower, or time).
c. Change either management strategy or
outcome.
Conclusions
3D echocardiogram was more accurate than 2D
echocardiogram in determining the length and
the ampulla of the PDA. The study clarified the
role of RT3DE for anatomic description of the
PDA using gated 3D color flow which was
achieved in 78.5% of the study population. Never-
theless the use of 3D echocardiogram in the set-
ting of pediatric patients with rapid heart rates
and small vascular structures like the PDA could
not provide major advantage over the standard
2D echocardiogram and angiography from the
clinical point of view. The ongoing development
in the field of 3D echocardiography should
O
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2012;24:177–186overcome the shortcomings shown in this study
and have its impact on the accurate assessment
and selection of the management strategies for ex-
tra cardiac vascular structures in the near future.Conflict of Interest
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